Trial Profile
A Phase II Multicenter,Open-Label, Clinical And Pharmacokinetic Study Of Aplidin As A 1-Hour Weekly IV Infusion, In Patients With Relapsed Or Refractory Indolent Non-Hodgkin's Lymphoid Neoplasms
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Plitidepsin (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 13 Jul 2011 New trial record